As the leading biopharmaceutical trade association, PhRMA is committed to driving efforts to address these inequities and push for better health outcomes for underserved communities. In 2020 we committed to taking on this leadership role and created the PhRMA Equity Initiative. Since then, we have dedicated significant time and resources toward areas where we can drive real progress--namely health equity, clinical trial diversity and talent.

We know meaningful change can only arise when we work in good partnership and rebuild trust with the communities who have been impacted by inequities for years. That’s why we’re proud to show that 2022 was a year of collaboration and action. Ultimately, PhRMA’s enduring commitment is to be a force in the push for equity. The partnerships, grants, events, and advocacy summarized in this report represent the progress we’ve made built on the commitments we keep.